First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Each year Mitchell celebrates one of its partners through the "mPower Award" highlighting innovative and transformational initiatives taken on in t
On this episode of Mitchell’s mPower podcast series, Product Management Director Chris Williamson joins our host, Shelley Callahan, senior director
The stories Natasha Charleston heard were haunting.
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
The quarterly LOR summary is produced by
For more than six decades, innovators have attempted to unlock the full potential of artificial intelligence (AI).